Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting the hallmarks of ovarian cancer: The big picture.
Petrillo M, Nero C, Amadio G, Gallo D, Fagotti A, Scambia G. Petrillo M, et al. Among authors: amadio g. Gynecol Oncol. 2016 Jul;142(1):176-183. doi: 10.1016/j.ygyno.2016.03.037. Epub 2016 Apr 7. Gynecol Oncol. 2016. PMID: 27058837 Review.
Controversy in treatment of advanced ovarian cancer.
Scambia G, Salutari V, Amadio G. Scambia G, et al. Among authors: amadio g. Lancet Oncol. 2013 Sep;14(10):920-1. doi: 10.1016/S1470-2045(13)70391-7. Lancet Oncol. 2013. PMID: 23993374 No abstract available.
Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients.
Lorusso D, Scambia G, Amadio G, di Legge A, Pietragalla A, De Vincenzo R, Masciullo V, Di Stefano M, Mangili G, Citterio G, Mantori M, Lambiase A, Bordignon C. Lorusso D, et al. Among authors: amadio g. Br J Cancer. 2012 Jun 26;107(1):37-42. doi: 10.1038/bjc.2012.233. Epub 2012 May 29. Br J Cancer. 2012. PMID: 22644293 Free PMC article. Clinical Trial.
An update on the pharmacotherapy for endometrial cancer.
Amadio G, Masciullo V, Stefano L, Scambia G. Amadio G, et al. Expert Opin Pharmacother. 2013 Dec;14(18):2501-9. doi: 10.1517/14656566.2013.849241. Epub 2013 Oct 21. Expert Opin Pharmacother. 2013. PMID: 24138224 Review.
The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer.
Pignata S, Scambia G, Lorusso D, De Giorgi U, Nicoletto MO, Lauria R, Mosconi AM, Sacco C, Omarini C, Tagliaferri P, Ferrandina G, Cinieri S, Savarese A, Valabrega G, Pisano C, Salutari V, Raspagliesi F, Kopf B, Cecere SC, Amadio G, Maltese G, Di Napoli M, Greggi S, Signoriello S, Daniele G, Sacco A, Losito S, Normanno N, Perrone F, Gallo C, Piccirillo MC; MITO Investigators. Pignata S, et al. Among authors: amadio g. Gynecol Oncol. 2019 Jun;153(3):535-540. doi: 10.1016/j.ygyno.2019.03.260. Epub 2019 Apr 9. Gynecol Oncol. 2019. PMID: 30979589 Free article. Clinical Trial.
63 results